{"id":89967,"date":"2023-11-27T16:40:25","date_gmt":"2023-11-27T11:10:25","guid":{"rendered":"http:\/\/finservwealth.com\/kronox-lab-sciences-files-draft-papers-for-ipo-with-sebi\/"},"modified":"2023-11-27T16:40:25","modified_gmt":"2023-11-27T11:10:25","slug":"kronox-lab-sciences-files-draft-papers-for-ipo-with-sebi","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/kronox-lab-sciences-files-draft-papers-for-ipo-with-sebi\/","title":{"rendered":"Kronox Lab Sciences files draft papers for IPO with SEBI"},"content":{"rendered":"<p> The firm is likely to mobilise around Rs 150 crore through the offer, which will comprise a fresh issue of shares worth Rs 45 crore and an offer for sale of 78 lakh shares<\/p><div id=\"finse-2383914328\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/kronox-lab-sciences-files-draft-papers-for-iposebi_17351191.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The firm is likely to mobilise around Rs 150 crore through the offer, which will comprise a fresh issue of shares worth Rs 45 crore and an offer for sale of 78 lakh shares The firm is likely to mobilise around Rs 150 crore through the offer, which will comprise a fresh issue of shares worth Rs 45 crore and an offer for sale of 78 lakh shares\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/kronox-lab-sciences-files-draft-papers-for-iposebi_17351191.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The firm is likely to mobilise around Rs 150 crore through the offer, which will comprise a fresh issue of shares worth Rs 45 crore and an offer for sale of 78 lakh shares<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/kronox-lab-sciences-files-draft-papers-for-iposebi_17351191.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The firm is likely to mobilise around Rs 150 crore through the offer, which will comprise a fresh issue of shares worth Rs 45 crore and an offer for sale of 78 lakh shares The firm is likely to mobilise around Rs 150 crore through the offer, which will comprise a fresh issue of shares worth Rs 45 crore and an offer for sale of 78 lakh shares\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/kronox-lab-sciences-files-draft-papers-for-iposebi_17351191.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The firm is likely to mobilise around Rs 150 crore through the offer, which will comprise a fresh issue of shares worth Rs 45 crore and an offer for sale of 78 lakh shares<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-89967","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2021\/200x200\/P\/Pharma_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/89967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=89967"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/89967\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=89967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=89967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=89967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}